# Mohit Trikha

> Mohit Trikha is the CEO of Kivu Bioscience, a clinical-stage biotech in San Mateo building next-generation antibody-drug conjugates for solid tumors. A biochemist by training with more than 25 years in oncology, he has helped move over 40 programs from the lab bench toward the clinic and contributed to approved drugs including Kadcyla, Polivy and vismodegib. His pitch for Kivu is deceptively simple: make cancer medicines that patients can actually stay on.

- **Role:** Chief Executive Officer at Kivu Bioscience
- **Organizations:** Kivu Bioscience, AbbVie, Apple Tree Partners, Genentech, Centocor / Johnson & Johnson, Triphase Accelerator
- **Nationality:** American
- **Education:** B.S. in Biochemistry, California State University, Los Angeles, Ph.D. in Biochemistry and Molecular Biology, University of Southern California
- **Known for:** Advanced more than 40 oncology programs from target identification to clinical trials, Contributed to the development of approved drugs including Kadcyla, Polivy, vismodegib, Sylvant and Emerilis, Led oncology early development at AbbVie across ADCs, bispecifics and CAR-T therapies

## Career timeline

- **Early career** — Research and drug development roles at Genentech and Centocor / Johnson & Johnson
- **2010s** — Vice President and Head of Oncology Early Development at AbbVie; site head of AbbVie Bay Area
- **2010s-2020s** — Leadership at Triphase Accelerator and Venture Partner at Apple Tree Partners
- **2024** — Joins Kivu Bioscience; company raises $92M Series A
- **2026** — Appointed Chief Executive Officer of Kivu Bioscience on April 14

## Achievements

- Advanced more than 40 oncology programs from target identification to clinical trials
- Contributed to the development of approved drugs including Kadcyla, Polivy, vismodegib, Sylvant and Emerilis
- Led oncology early development at AbbVie across ADCs, bispecifics and CAR-T therapies
- Published more than 40 papers and filed multiple patents; presented at AACR, ASCO, ASH and EHA
- Named CEO of Kivu Bioscience in April 2026

## Latest updates

- **2026-04** — Appointed Chief Executive Officer of Kivu Bioscience, stepping up from President and COO.
- **2026-02** — Spoke on lessons from early ADC development at the World ADC and Biotech Showcase events.

## Links

- Website: https://kivubioscience.com
- LinkedIn: http://www.linkedin.com/in/mohit-trikha-9771338

---

Profile page: https://yespress.io/mohit-trikha
Published by YesPress — https://yespress.io
Last updated: 2026-08-21